Bangladesh requests $500 million support from World Bank for COVID-19 vaccine

As mentioned on the Press Release, the Bangladeshi government will use the World Bank funds for procurement, preservation, transportation and distribution of the vaccine.


1 min read
Bangladesh requests $500 million support from World Bank for COVID-19 vaccine

Bangladesh has requested $500 million support from the World Bank for COVID-19 vaccine in the country. As mentioned on the Press Release, the Bangladeshi government will use the World Bank funds for procurement, preservation, transportation and distribution of the vaccine. The latest funds will be in addition to the money that has aready been allocated under IDA 19 for Bangladesh in the current financial year.

Bangladesh Health Ministry had refused to co-finance the clinical trials of an experimental Chinese COVID-19 vaccine developed by Sinovac Biotech in this month.

On September 24, Sinovac Biotech Ltd in a letter said that the trial of the COVID-19 vaccine would be delayed unless the government provide the funds, although the company was supposed to bear the costs as per agreement, The Daily Star reported.

In response to Sinovac Biotech's letter, Bangladesh Health Minister Zahid Maleque said that Sinovac Biotech Ltd should run the trial with their own money because that is what they said they would do when they had sought approval.

"And that's why they were given permission," he said.

Maleque added, "A country's job is done when it approves the clinical test of a vaccine. They never asked for co-funding when they sought approval for trial. This is not a contract we have with the Chinese government. This is a private company and we can not have a co-funding with a private company".

As the Coronavirus continues to spread all over the world, so far, Bangladesh has recorded over 397,507 positive COVID-19 cases. Out of which, over 290,000 people have recovered from the virus while 5,780 have succumbed to death. Currently, the total number of active cases in the Bangladesh is 80,481.

GO TOP